1. Abstract
Recent genome-wide association studies have identified numerous single nucleotide polymorphisms (SNPs) associated with subcortical brain volumes. These studies have been undertaken in largely adult cohorts. To better understand the role of genetic variability in foetal and perinatal brain development, we investigate how common genetic variation affects subcortical brain development in a cohort of 208 term-born infants from the Developing Human Connectome Project.
We examine six SNPs, that have shown robust associations with subcortical brain volumes in adult studies and ask if these associations exist at birth. We then investigate whether genome-wide polygenic scores (GPSs) for adult subcortical brain volumes are predictive of the corresponding neonatal brain volume. Finally, we explore the relationship between GPSs for psychiatric disorders and subcortical brain volume at birth.
We find the association between SNP rs945270 and putamen volume, seen in adults, is present at birth (p=3.67×10-3, β=0.13, SE=0.04). The associations between SNP rs61921502 and hippocampal volume and SNP rs11111090 and brainstem volume are also nominally present in our neonatal cohort. We show that neonatal hippocampal, brainstem, putamen and thalamic volume are all significantly associated with the GPSs for their corresponding volume in adults. Finally, we find that GPSs for five psychiatric disorders and a cross-disorder score are not significantly predictive of subcortical brain volumes or total brain volume at birth. Our results indicate that SNPs important in shaping adult subcortical brain volume are also significant in foetal and perinatal brain development.
Key Points
We show that the association between the single nucleotide polymorphism, rs945270 and putamen volume, seen in adults, is present in neonates.
We show that neonatal hippocampal, putamen, brainstem and thalamic volumes are all significantly predicted by the genome-wide polygenic scores for corresponding adult brain volumes.
We do not find any robust association between genome-wide polygenic scores for psychiatric disorders and neonatal brain volume although we observe several nominal associations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Developing Human Connectome Project was funded by the European Research Council under the European Union Seventh Framework Programme (FP/20072013)/ERC Grant Agreement no. 319456. This work was supported by the NIHR Biomedical Research Centres at Guys and St Thomas NHS Trust and the South London and Maudsley NHS Trust; the ESPRC/Wellcome Centre for Medical Engineering at Kings College London ((WT 203148/Z/16/Z); and the MRC Centre for Neurodevelopmental Disorders. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. DB received support from a Wellcome Trust Seed Award in Science [217316/Z/19/Z]. LCG received support from the Comunidad de Madrid-Spain Support for R&D Projects [BGP18/00178]. H.C is an academic clinical lecturer in Clinical Genetics at Kings College London and her research is supported by the NIHR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the United Kingdom Health Research Authority (Research Ethics Committee reference number: 14/LO/1169, IRAS 138070) and written informed consent was obtained from parents.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Ethics Approval Statement This study is based on a prospective sample of neonates participating in the dHCP (http://www.developingconnectome.org/). Data collection for the project took place in London, UK from 2015 to 2020. This project has received UK NHS research ethics committee approval (14/LO/1169, IRAS 138070), and written informed consent was obtained from parents.
Data availability statement: The dHCP is an open-access project. The imaging and demographic data used in this study can be downloaded by registering at https://data.developingconnectome.org/
Funding statement: The Developing Human Connectome Project was funded by the European Research Council under the European Union Seventh Framework Programme (FP/20072013)/ERC Grant Agreement no. 319456. This work was supported by the NIHR Biomedical Research Centres at Guys and St Thomas NHS Trust and the South London and Maudsley NHS Trust; the ESPRC/Wellcome Centre for Medical Engineering at Kings College London ((WT 203148/Z/16/Z); and the MRC Centre for Neurodevelopmental Disorders. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
DB received support from a Wellcome Trust Seed Award in Science [217316/Z/19/Z]. LCG received support from the Comunidad de Madrid-Spain Support for R&D Projects [BGP18/00178]. H.C is an academic clinical lecturer in Clinical Genetics at Kings College London and her research is supported by the NIHR.
Conflict of Interest Disclosure The authors declare no conflict of interest.
Data Availability
The dHCP is an open‐access project. The imaging and demographic data used in this study can be downloaded by registering at https://data.developingconnectome.org/
